Aldermann et al 1991 - Aldermann MH, Madhaven S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. New Engl J Med. 1991; 324: 1098-104.

Aviram et al 1998 - Aviram M, Fuhrman B. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants. Mol Cell Biochem. 1998; 188: 149-59.

Babior 1987 - Babior BM. The respiratory burst oxydase. Trend biochem Sci. 1987; 12: 241-243.

Bartha 1978 - Bartha GW, Nugent CA. Routine chest roentgenograms and electrocardiograms. Usefulness in the hypertensive wo rkup. Arch Intern Med. 1978; 138: 1211-1213.

Bevilacqua et al 1989 - Bevilacqua MP, Stengelin S, Gimbrone MA. Seed B Endothelial leukocyte adhesion molecule-1. An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 1989; 243: 1160-1165.

Black et al 1997 - Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumor-necrosis factor-alpha from cells. Nature. 1997; 385: 729-33.

Blann 1998 - Blann AD. Von Willebrandt factor and the endothelium in vascular disease. Br J Biomed Sci. 1993; 50: 125-134.

Blann and Waite 1996 - Blann AD, Waite MA. von Willebrandt factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis. Coron-Artery-Dis. 1996; 7(2): 143-147.

Blann et al 1994 - Blann AD, Tse W, Maxwell SJR, Waite MA. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertension. 1994; 12: 925-928.

Blumenfeld 2001 - Blumenfeld JD, Laragh JH. Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens. 2001; 14: 1154-1167.

Braunwald 1997 - Braunwald E. Shattock Lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997; 337: 1360-1369.

Bulpitt et al 1994 - Bulpitt Ch J, Palmer AJ, Fletcher AE. Optimal blood pressure control in treated hypertensive patients. Report from the Department of Health Hypertension Care Computing Project (DHCCP). Circulation. 1994; 90: 225-232.

Burt et al 1995 - Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension. 1995; 26: 60-69.

Carini und Duncia 1988 - Carini DJ. Duncia JV. Angiotensin II receptor blocking imidazoles. Eur Patent Application. 1988; 0253310.

Chalmers et al, WHO-ISH 1999 - Chalmers J et al,1999 WHO-ISH Hyper-tension Guidelines Committee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999; 17: 151-185.

Chang et al 1995 - Chang MY, Sasahara M, Chait A, Raines EW, Ross R. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. II. Cellular composition and proliferation. Arterioscler Thromb Vasc Biol. 1995; 15: 1631-1640.

Chapelsky et al 1998 - Chapelsky M, PharmD, Martin D, Pharm D, Tenero D, PharmD, Ilson B, Boike S, PharmD, Etheredge R, Jorkasky D. A Dose Proportionally Study of Eprosartan in Healthy Male Volunteers. J Clin Pharmacol. 1998; 38: 34-39.

Cross 1991 - Cross AR, Jones OTG. Enzymic mechanisms of superoxide production. Biochim Biophys Acta. 1991; 1057: 281-298.

Dansky et al 2001 - Dansky HM, Barlow CB, Lominska C, Sikes JL, Kao C, Weinsaft J, Cybulsky MI, Smith JD. Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arteriosclerosis Thrombosis and Vascular Biology. 2001; 21(10): 1662-1667.

Davies et al 1993 - Davies MJ, Gordon IL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 1993; 171: 223-229.

De Caterina et al 1997 - De Caterina R, Basta G, Lazzerini G, et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol. 1997; 17: 2646-2654.

de Villiers et al 1998 - de Villiers WJS, Smith JD, Miyata M, Dansky HM, Darley E, Gordon S. Macrophage phenotype in mice deficient in both macrophage-colony stimulating factor (op) and apolipoprotein E. Arterioscler Thromb Vasc Biol. 1998; 18: 631-640.

Dechend et al 2003 - Dechend R, Viedt C, Müller D, Ugele B, Brandes R, Wallukat G, Park JK, Janke J, Barta P, Theuer J, Fiebeler A, Homuth V, Dietz R, Haller H, Kreuzer H, Luft F . AT1 Receptor Agonistic Antibodies From Preeclamptic Patients Stimulate NADPH Oxidase. Circulation. 2003; 107: 1632-1639.

DeLeo et al 1998 - DeLeo F, Renee J, McCormick S, Nakamura M, Apicella M, Weiss J, Nauseef W. Neutrophils Exposed to Bacterial Lipopolysaccharide Upregulate NADPH Oxidase Assembly. J Clin Invest. 1998; 101: 455-463.

DeSouza et al 1997 - DeSouza CA, Dengel DR, Macko RF, Cox K, Seals DR. Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension. Am J Hypertens. 1997; 10: 1335-1341.

Diaz et al 1997 - Diaz Mn, Frei B, Vita JA, Keaney JFJr. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997; 337: 408-416.

Dina und Jafari 2000 - Dina R, Jafari MI. Angiotensin II - receptor antagonists: an overview. Am J Health Syst Pharm. 2000; 157(13): 1231-1241.

DLBB eV - DHG 1999 - Deutsche Liga zur Bekämpfung des hohen Blutdruckes e.V., Deutsche Hypertonie Gesellschaft. Merkblatt Empfehlungen zur Hochdruckbehandlung. Auflage 15. Heidelberg, 10.04.2001. 1-23.

Dörffel et al 1999 - Dörffel Y, Lätsch C, Stuhlmüller B, Schreiber S, Scholze S, Burmester GR, Scholze J. Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension. 1999; 34: 113-117.

Dörffel et al 2001 - Dörffel Y, Franz S, Pruß A, Neumann G, Rohde W, Burmester GR, Scholze J. Preactivated monocytes from hypertensive patients as a factor for atherosclerosis. Atherosclerosis. 2001; 157: 151-160.

Dörffel et al 2003 - Dörffel Y, Wallukat G, Bochnig N, Homuth V, Herberg M, Dörffel W, Pruss A, Chaoui R, Scholze J. Agonistic AT(1) receptor autoantibodies and monocyte stimulation in hypertensive patients. Am J Hypertens. 2003; 16 (19): 827-833.

Escargueil-Blanc et al 2001 - Escargueil-Blanc I, Salvayre R, Vacarese N, Jurgens G, Darblade B, Arnal JF, Parthasarathy S, Negre-Salvayre A. Mildly oxidized LDL induces activation of platelet -derived growth factor beta-receptor pathway. Circulation. 2001; 104(15): 1814-1821.

Falcone et al 1991 - Falcone DJ, McCaffrey TA, Vergilio JA. Stimulation of macrophage erokinase expression by polyanions is protein kinase C-dependent and requires protein and RNA synthesis. J Biol Chem. 1991; 266: 22726-22732.

Fan et al 1993 - Fan J, Shimokama T, Haraoka S, Tokunaga O, Watanabe T. Monocyte-endothelial cell interactions in vitro, with reference to the influence of interleukin-1 and tumor necrosis factor. Biol Cell. 1993; 79: 17-26.

Fiotti et al 1999 - Fiotti N, Giansante C, Ponte E, et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis. 1999; 145: 51-60.

Folcik et al 1997 - Folcik VA, Aamir R, Cathcart MK. Cytokine modulation of LDL oxidation by activated human monocytes. Arterioscler Thromb Vasc Biol . 1997; 17: 1954-1961.

Frick et al 1987 - Frick MH, Elo O, Haapa K. Helsinki heart study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med. 1987; 31: 1237-1245.

Frostegard et al 1992 - Frostegard J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb. 1992; 12(4): 461-467.

Frostegard et al 1998 - Frostegard J, Wu R, Gillis-Haegerstrand C, Lemne C, de Faire U. Antibodies to endothelial cells in borderline hypertension. Circulation. 1998; 98: 1092-1098.

Fruebis et al 1997 - Fruebis J, Gonzales V, Silvestre M, Palinski W. Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL-receptor deficient rabbits during early atherogenesis. Arterioscler Thromb Vasc Biol. 1997; 17: 1289-1302.

Fukai et al 1998 - Fukai T, Galis ZS, Meng XP, Parthasarathy S, Harrison DG. Vascular expression of extracellular superoxide dismutase in atherosclerosis. J Clin Invest. 1998; 101: 2101-2111.

Fukai et al 1999 - Fukai T,Siegfried MR, Ushio-Fukai M, Griendling KK, Harrison DG. Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res. 1999; 85: 23-28.

Fukui et al 1997 - Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q 4th, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res. 1997; 80: 45-51.

Geng und Libby 1995 - Geng Y-J, Libby P. Evidence of apoptosis in advanced human atheroma: colocalization with interleukin-1beta-converting enzyme. Am J Pathol. 1995; 147: 251-266.

Gerszten et al 1999 - Gerszten RE, Garcia-Zepeda EA, Lim YC, et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature. 1999; 398: 718-723.

Giachelli et al 1998 - Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Path. 1998; 152: 353-358.

Griendling et al 1994 - Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured smooth muscle cells. Circ Res. 1994; 74: 1141-1148.

Griendling et al 1997 - Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation. 1997; 96: 3264-3265.

Griendling et al 2000 - Griendling K, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000; 86: 494-501.

Hahn et al 1994 - Hahn AWA, Jonas F, Bühler FR, Resink TJ. Activation of human peripheral blood monocytes by angiotensin II. FEBS Lett. 1994; 347: 178-180.

Hajjar und Haberland 1997 - Hajjar DP, Haberland ME. Lipoprotein trafficking in vascular cells: molecular Trojan horses and cellular saboteurs. J Biol Chem. 1997; 272: 22975-22978.

Hansson et al 1989 - Hansson GK, Jansson L, Seifert PS, Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis. 1989; 9: 567-578.

Hansson et al 1998 - Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998; 351: 1755-1762.

Hansson et al 1999 - Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmaki K, Dahlof B, de Faire U, Morlin C, Karlberg BE, Wester PO, Bjorck JE. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet. 353: 1999; 611-616.

Hedner 1999 - Hedner T. Management of hypertension: the advent of a new angiotensin II receptor antagonist. J Hypertens Suppl. 1999 Jun; 17 (2): S21-5.

Hedner 2002 - Hedner T. The clinical profile of the angiotensin II receptor blocker eprosartan. Journal of Hypertension. 2002; 20(suppl 5): S33-S38.

Heinonen et al 1994 - Heinonen OP, HuttunenJK, Manninen V. The Helsinki heart study: Coronary heart disease incidence during extended follow up. J Intern Med. 1994; 235: 41-49.

Hennekens et al 1996 - Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of longterm supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996; 334: 1145-1149.

Herren et al 1997 - Herren B, Raines EW, Ross R. Expression of a disintegrin-like protein in cultured human vascular cells and in vitro. FASEB J. 1997; 11: 173-180.

Hogeson und Fridovich 1997 - Hodgeson EK, Fridovich I. The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme. Biochemistry. 1975; 14: 5294-5299.

Hollenbaugh et al 1995 - Hollenbaugh D, Mischel-Petty N, Edwards CP, et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med. 1995; 182: 33-40.

HOPE Investigators 2000 - Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events inhigh risk patients. N Engl J Med. 2000; 342: 145-153.

Hwang et al 1997 - Hwang S-J, Ballantyre CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-Selektin in carotid atherosclerosis and incident coronary artery disease cases: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 1997; 96: 4219-4225.

Jackson et al 1997 - Jackson LA, Campbell LA, Schmidt RA, et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma : evaluation of the innocent bystander hypothesis. Am J Pathol . 1997; 150: 1785-1790.

Jaffe et al 1973 - Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 1973; 52: 2745-2756.

Jelinek et al 1987 - Jelinek DF, Lipsky PE. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleucin-1. J Immunol. 1987; 139: 2970-2976.

Jimenez et al 2001 - Jimenez A, Arriero MM, Lopez-Blaya A, Gonzalez-Fernandez F, Garcia R, Fortes J, Millas I, Velasco S, de Miguel LS, Rico L, Farre J, Cascado S, Lopez-Farre A. Regulation of endothelial nitric oxide synthase expression in the vascular wall and in mononuclear cells from hypercholesterolemic rabbits. Circulation. 2001; 104(15): 1822-1830.

Kahan et al 1997 - Kahan T, Lindquist M, Nussberger J, Melcher A, Hjemdahl P. Plasma angiotensins and human forearm circulation: effects of sympatho-adrenal activation. Acta Physiol Scand. 1997; 159: 107-111.

Khoo et al 1992 - Khoo JC, Miller E, Pio F, Steinberg D, Witzum JL. Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. Arteriolar Thromb. 1992; 12: 1258-1266.

Kim and Iwao 2000 - Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II - mediated cardiovascular and renal diseases. Pharmacol Rev. 2000; 52: 11-34.

Kitahora et al 1988 - Kitahora T, Suzuki K, Asakura, Yoshida T, Suematsu M, Watanabe M, Aiso S, Tsuchiya M. Active Oxygen Species Generated by Monocytes and Polymorphonuclear Cells in Crohn´s Disease. Digestive Diseases and Sciences. 1988; 8: 951-955.

Klose 1996 - Klose G. Wirksamkeit lipidsenkender Intervention für die Prävention kardiovaskulärer Erkrankungen. Klinikarzt. 1996; 5/25: 147-150.

Kricka 1993 - Kricka L. Ultrasensitive Immunoassay Techniques. Clin Biochem. 1993; 26(5): 325-31.

Lacy et al 1998 - Lacy F, O´Connor DT, Schmid-Schönbein GW. Plasma hydrogen peroxide production in hypertensive and normotensive subjects at genetic risk of hypertension. J Hypertens. 1998; 16: 291-303.

Laragh 1993 - Laragh JH. The renin system: a new understanding of the complications of hypertension and their treatment. Drug Res. 1993; 43: 247-254.

Laursen et al 1997 - Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin-II induced but not catecholamine-induced hypertension. Circulation. 1997; 95: 588-593.

Legrand-Poels et al 1997 - Legrand-Poels S, Maniglia S, Boelaert J, Piette J. Activation of the Transcription Factor NF-kB in Lipopolysaccharide-Stimulated U937 Cells . Biochem Pharmacol. 1997; 53(3): 339-346.

Leonard und Yoshimura 1990 - Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today. 1990; 11: 97-101.

Levine et al 1995 - Levine GN, Keaney JF Jr, Vita JR. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med. 1995; 332(8): 512-521.

Li et al 2003 - Li JM, Shah A. Mechanism of Endothelial Cell NADPH Oxidase Activation by Angiotensin II. JBC. 2003; 14: 12094-12100.

Libby et al 1997 - Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 1997; 96: 4095-4103.

Liu et al 1996 - Liu Y, Liu T, McCarron R, Spatz M, Feuerstein G, Hallenbeck J, Sirén A-L. Evidence for activation of endothelium and monocytes in hypertensive rats. Am J Physiol. 1996; 270: H2125-H2131.

LRCP 1984 - The Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results: I. Reduction in incidence of coronary heart disease. JAMA. 1984; 251: 351-364.

Luhm et al 1997 - Luhm J, Kirchner H, Rink L. One way synergistic effect of low superantigen concentrations on lipopolysaccharide induced cytokine production. J Interferon Cytokine Res. 1997; 17: 229-238.

Lüscher et al 1995 - Lüscher TF, Noll G. The pathogenesis of cardiovascular disease: role of endothelium as a target and mediator. Atherosclerosis. 1995; 118: S81-S90.

Mach et al 1997 - Mach F, Schönbeck U, Bonnfoy J-Y, Pober JS, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation. 1997; 96: 396-399.

Mach et al 1998 - Mach F, Schönbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature. 1998; 394: 200-203.

MacMahon et al 1990 - MacMahan S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990; 335: 765-774.

Mancia et al 1993 - Mancia G, Di Rienzo M, Parati G. Ambulatory blood pressure monitoring use in hypertension research and clinical practice. Hypertension. 1993; 21: 510-524.

Marklund 1992 - Marklund SL. Regulation by cytokines of extracellular superoxide dismutase isoenzymes in fibroblasts. J Biol Chem. 1992; 267: 6696-6701.

McCarron et al 1994 - McCarron RM, Wang L, Siren AL, Spatz M, Halenbeck JM. Monocyte adhesion to cerebmicrovascular endothelial cells. Am J Physiol. 1994; 267: H2491-H2497.

Mensah 2002 - Mensah G. The global burden of hypertension: good news and bad news. Cardiology Clinics. 2002; 20(2): 181-185.

Middecke 1998 - Middecke M. Ambulante 24 - Stunden - Blutdruckmessung (ABDM). Dtsch Med Wschr. 1998; 123: 1426-1430.

Muller et al 1993 - Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leucocytes. J Exp Med. 1993; 178: 449-460.

Murray et al 1996 - Murray CJL, Lopez AD, eds. Hrsg.: World Health Organization: The Global Burden of Disease. A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Auflage 1. Cambridge, MA, Harvard University Press, 1996.

Nagel et al 1994 - Nagel T, Resnick N, Atkinson WJ, Dewey CF, Jr, Gimbrone MA, Jr . Shear stress selectively upregulates intercellular adhesion molcule-1 expression in cultured human vascular endothelial cells. J Clin Invest. 1994; 94: 885-891.

Nauseef 1990 - Nauseef WM. Myeloperoxidase deficiency. Hematol Pathol. 1990; 4: 165-178.

Okamura et al 1999 - Okamura A, Rakugi H, Ohishi M, Yanagati Y, Takiuchi S, Moriguchi K, Fenessy P, Higaki J, Ogihara. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. Journal of Hypertension. 1999; 17: 537-545.

Omenn et al 1996 - Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996; 334: 1150-1155.

Oparil 2002 - Oparil S. Are there meaningful differences in blood pressure control with current antihypertensive agents. AJH. 2002; 15: 14S-21S.

Oury et al 1997 - Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase: a regulator of nitric oxide bioavailability. Lab Invest. 1996; 271: 23317-23321.

Pagano et al 1998 - Pagano P, Chanock S, Siwik D, Colucci W, Clark J. Angiotensin II Induces p67phox mRNA Expression and NADPH Oxidase Superoxide Generation in Rabbit Aortic Adventitial Fibroblasts. Hypertension. 1998; 32: 331-337.

Peters 2002 - Peters H, Baldwin M, Clarke M. The utility of laboratory data in the evaluation of the asymptomatic hypertensive patient. Ann Emerg Med. 2002; 40: S48.

Plosker und Foster 2000 - Plosker GL, Foster RH. Eprosartan: a review of its use in the management of hypertension. Drugs. 2000; 60(1): 177-201.

Prospective Studies Collaboration 1995 - Prospective Studies Collaboration 1995. Cholesterol diastolic blood pressure and stroke: 13 000 strokes in 45 000 people in 45 prospective cohorts. Lancet. 1995; 346: 1647-1653.

Pueyo et al 1998 - Pueyo ME, Arnal JF, Rami J, Michel J-B. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol. 1998; 274: C214-C220.

Qiao et al 1997 - Qiao J-H, Tripathi J, Mishra NK, et al. Role of macrophage colony stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am J Pathol. 1997; 150: 1687-1699.

Rajagopalan 1996 - Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II - mediated hypertension in the rat increases vascular superoxide production via membrane NADH/ NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest. 1996; 97: 1916-1923.

Rajavashisth et al 1990 - Rajavashisth TB, Andalibi A, Territo MC, et al. Induction of endothelial cell expression of granulocyte and macrophage colony - stimulating factors by modified low-density lipoproteins. Nature. 1990; 344: 254-257.

Reaven et al 1993 - Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not beta-carotene. Arterioscler Thromb. 1993; 13: 590-600.

Rey et al 2001 - Rey F, Cifuentes M, Kiarash A, Quinn M, Pagano P. Novel competitive inhibitor of NAD (P) H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res. 2001; 89: 408-414.

Rimm et al 1993 - Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993; 328: 1450-1456.

Rosenfeld and Ross 1990 - Rosenfeld ME, Ross R. Macrophage and smooth muscle proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Atherosclerosis. 1990; 10: 680-687.

Ross 1993 - Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993; 362: 801-809.

Ross 1999 - Ross R. Atherosclerosis - an inflammatory disease. New Engl J Med. 1999; 340: 115-126.

Ross et al 1973 - Ross R, Glomsett JA. Atherosclerosis and the arterial smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science. 1973; 180: 1332-1339.

Rückert-Dörffel et al 1996 - Rückert-Dörffel Y, Schindler U, Heinig T, Nikolaus S, Raedler A, Schreiber S. IL-4 signaling mechanisms in inflammatory bowel disease mononuclear phagocytes. Inflamm Bowel Dis. 1996; 2: 244-252.

Rueckschloss et al 2001 - Rueckschloss U, Galle J, Holtz J, Zerkowski HR, Morawietz H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells - Antioxidative potential of hydroxymethylglutaryl coenzyme a reductase inhibitor therapy. Circulation. 2001; 104(15): 1767-1772.

Sasahara et al 1994 - Sasahara M, Raines EW, Chait A, et al. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation. J Clin Invest. 1994; 94: 155-164.

Sasaki et al 1987 - Sasaki DT, Dumas SE, Engleman EG. Discrimination of viable and nonviable cells using propidium iodide in two color immunofluorescence. Cytometry. 1987; 8: 413-420.

Schiffrin 2002 - Schiffrin EL, Canadian Institutes of Health Research (CIHR) Multidisciplinary Research Group on Hypertension. Beyond blood pressure: The endothelium and atherosclerosis progression. AJH. 2002; 15: 115S-122S.

Scholze 1999 - Scholze J. Hypertonie. Auflage 2. Berlin, Blackwell Wissenschaftsverlag, 1999. Seiten 3,11,37. ISBN: 3-89412-393-1.

Schönbeck et al 1997a - Schönbeck U, Mach F, Sukhova GK, et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture. Circ Res. 1997; 81: 448-454.

Schönbeck et al 1997b - Schönbeck U, Mach F, Bonnefoy J-Y, Loppnow H, Flad H-D, Libby P. Ligation of CD40 activates interleukin-1beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin-1beta. J Biol Chem. 1997; 272: 19569-19574.

Schrader 1995 - Schrader J. Prognostische Bedeutung der 24-Stunden-Langzeitblutdruckmessung. Nieren- und Hochdruckkrankheiten. 1995; 24: 640-644.

Shen et al 1995 - Shen K, De Lano FA, Zweifach BW, Schmid-Schönbein GW. Circulating leucocyte counts, activation, and degranulation in Dahl hypertensive rats. Circ Res. 1995; 76: 276-283.

Shepherd et al 1995 - Shepherd J, Cobbe SM, Ford I for the West of Scotland Coronary Prevention Study Group . Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995; 333: 1301-1307.

Simon et al 1995 - Simon A, Levenson J. Stratification of vascular risk in hypertension and therapeutic perspective. Am J Hypertens. 1995; 8: 45S-48S.

Slama et al 2002 - Slama M, Susic D, Frohlich E. Prevention of hypertension. Current Opinion in Cardiology. 2002; 17: 531-536.

Sleight P et al 2001 - Sleight P, Yusuf S, Pogue J, Tsuyuki R, Diaz R, Probstfield J, for the Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Blood-pressure reduction and cardiovascular risk in HOPE study. Lancet. 2001; 358: 2130-2131.

Smalley et al 1996 - Smalley DM, Lin JH-C, Curtis ML, Kobari Y, Stemerman MB, Pritchard Jr KA. Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule-1. Arteroscler Thromb Vasc Biol. 1996; 16: 585-590.

SSSS Group 1994 - Scandinavian Simvastatin Survival Group. Randomized Trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4 S). Lancet. 1994; 344: 1383-1389.

Stampfer et al 1993 - Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993; 328: 1444-1449.

Staunton et al 1988 - Staunton DE, Marlin SD, Stratiwa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell. 1988; 52(6): 925-933.

Steinberg 1997 - Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997; 272: 20963-20966.

Stemme et al 1995 - Stemme S, Faber B, Holm J, Wiklund O, Witzum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA. 1995; 92: 3893-3897.

Stephens et al 1996 - Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet. 1996; 347: 781-786.

Stralin et al 1995 - Stralin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 1995; 15: 2032-2036.

Strawn et al 1999 - Strawn WB, Gallagher PE, Tallant EA, Ganten D, Ferrario CM. Angiotensin II AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats. J Cardiovasc Pharmacol. 1999; 33(3): 341-351.

Swei et al 1997 - Swei A, Lacy F, DeLano FA, Schmid-Schönbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension. 1997; 30: 1628-1633.

Swerlick et al 1992 - Swerlick RA, Lee KH, Li L-J, Sepp NT, Caughman SW, Lawley TJ. Regulation of vascular cell adhesion molecule 1 on human dermal microvascular cells. J Immunol. 1992; 149(2): 698-705.

Tenero et al 1998 - Tenero D, Martin D, Ilson B, Boyle D, Boike S, Carr A, Lundberg D, Jorkasky D. Effect of Ranitidine on the Pharmacokinetics of Orally Administered Eprosartan, an Angiotensin II Antagonist, in Healthy Male Volunteers. Ann Pharmacother. 1998; 32: 304-308.

Tribble et al 1997 - Tribble DL, Gong EL, Leeuwenburgh C, Heinecke JW, Carlson EL, Verstuyft JG, Epstein CJ. Fatty streak formation in fat-fed mice expressing human copper-zinc superoxide dismutase. Arterioscler Thromb Vasc Biol. 1997; 17: 1734-1740 und 3363 [erratum] .

Tummala et al 1999 - Tummala PE, Chen X - L, Sundell CL, et al. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature. Circulation. 1999; 100: 1223-1229.

Ushio-Fukai et al 1999 - Ushio-Fukai M, Alexander R, Akers M, Yin Q, Fujiyo Y, Walsh K, Griendling K. Reactive oxygen species mediate the activation of Akt / proteinkinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem. 1999; 274: 22699-22704.

Vaddi et al 1994 - Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased Secretion of Tumor Necrosis Factor-alpha and Interferon-gamma by mononuclear Leucocytes in Patients with Ischemic Heart Disease - Relevance in Superoxide Anion Generation. Circulation. 1994; 90: 694-699.

van de Stolpe et al 1996 - van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med. 1996; 74(1): 13-33.

Vanhoutte und Boulanger 1995 - Vanhoutte PM, Boulanger CM. Endothelium - dependent responses in hypertension. Hypertens Res. 1995; 18: 87-98.

Violi et al 1996 - Violi F, Criqui M, Longoni A, Castiglioni C, the A.D.E.P. Group. Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study. Atherosclerosis. 1996; 120: 25-35.

Wang et al 2001 - Wang H, Xu S, Johns D, Du Y, Quinn M, Cayatte A, Cohen R. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to Angiotensin II in mice. Circ Res. 2001; 88: 88947-88953.

Watanabe et al 1998 - Watanabe T, Fan J. Atherosclerosis and inflammation mononulear cell recruitment and adhesion molecules with reference to the implication of ICAM-1/LFA-1 pathway in atherogenesis. Int J Cardiol. 1998; 66: 45-53.

Wick et al 1995 - Wick G, Schett G, Amberger A, Kleindienst R, Xu Q. Is atherosclerosis an immunologically mediated disease. Immunol Today. 1995; 16: 27-33.

Wick et al 1997 - Wick G, Romen M, Amberger A, et al. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. FASEB J. 1997; 11: 1199-1207.

Wiklund et al 1997 - Wiklund I, Halling K, Ryden - Bergsten T. Bessert sich durch eine Blutsrucksenkung die Befindlichkeit eines Hypertonikers? Ergebnisse der HOT - Studie (Hypertension Optimal Treatment Study) hinsichtlich der Lebensqualität. Blood Pressure. 1997; 6: 357-364.

Yim et al 1990 - Yim MB, Chock PB, Stadtman ER. Copper, zinc superoxide dismutase catalyses hydroxyl radical production from hydrogen peroxide. Proc Natl Acad Sci USA. 1990; 87: 5006-5010.

Ylä-Herttuala et al 1989 - Ylä-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989; 84: 1086-1095.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: